🔎 Trials Near Me

Utama › Kanser Serviks › Massachusetts › Boston

Kajian klinikal Kanser Serviks di Boston, MA

18 kajian untuk Kanser Serviks sedang mencari peserta di lokasi dalam dan sekitar Boston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Distance-Based Exercise to Preserve Function and Prevent Disability

Mengambil peserta
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07059884

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Mengambil pesertaFasa 1
  • Massachusetts General Hospital, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06465069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Mengambil pesertaFasa 2
  • Dana-Farber Cancer Institute - Oncology Department, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06760819

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Mengambil pesertaFasa 1/2
  • Tufts Medical Center, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06047379

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Mengambil pesertaFasa 1
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05983432

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Mengambil pesertaFasa 1/2
  • Massachusetts General Hospital, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07109726

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Mengambil pesertaFasa 1
  • Dana Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06293898

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Mengambil pesertaFasa 1
  • Mass General Cancer Center, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07227168

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Mengambil pesertaFasa 1
  • Normunity Investigational Site, Boston
  • Normunity Investigational Site, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07182149

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Massachusetts General Hospital Cancer Center, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05592626

Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice, RCT

Mengambil peserta
  • Massachusetts General Brigham, Boston
Umur 21 hingga 70 · Wanita · Dikemas kini 7 Ogo 2026 · NCT06872346

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Mengambil pesertaFasa 1
  • Massachusetts General Hospital, Boston
  • Brigham & Women's Hospital, Boston
  • Beth Israel Deaconess Medical Center,East Campus Research Pharmacy, Boston
  • dan 2 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Jul 2026 · NCT04389632

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jun 2026 · NCT06993844

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Massachusetts General Hospital, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT06239194

Building Connections

Mengambil peserta
  • Disparities Research Unit, Massachusetts General Hospital, Boston
Umur 18 hingga 75 · Semua jantina · Dikemas kini 18 Nov 2025 · NCT07091032

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Mengambil pesertaFasa 2
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Wanita · Dikemas kini 5 Nov 2025 · NCT06677190

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Dana Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2025 · NCT05941507

Kajian Kanser Serviks di bandar lain

Kajian lain di Boston

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.